Manuel Nicolás
Hernández Guerra de Aguilar
Professeur Associé
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Nuestra Señora de Candelaria (8)
2023
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
-
Hematological Composite Scores in Patients with Inflammatory Bowel Disease
Journal of Clinical Medicine, Vol. 12, Núm. 23
2021
-
Carotid plaque assessment reclassifies patients with inflammatory bowel disease into very-high cardiovascular risk
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Insulin resistance is not increased in inflammatory bowel disease patients but is related to non-alcoholic fatty liver disease
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257
-
Qrisk3 performance in the assessment of cardiovascular risk in patients with inflammatory bowel disease
Journal of Clinical Medicine, Vol. 10, Núm. 18
2019
-
Chronic kidney disease staging with cystatin C or creatinine-based formulas: Flipping the coin
Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 287-294
-
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672